Related Experiment Video

Updated: Jul 7, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

[Gonadal function after cancer treatment in adult men]

Cecilie E Kiserud1, Henriette Magelssen, Peter Fedorcsak

  • 1Nasjonalt kompetansesenter for langtidsstudier, etter kreft, Radiumhospitalet Rikshospitalet, 0027 Oslo. cecilie.essholt.kiserud@radiumhospitalet.no

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|February 16, 2008
PubMed
Abstract

Insights

Cancer treatments like chemotherapy and radiation can impair male fertility. Discussing fertility preservation options, such as semen freezing, is crucial for male cancer patients before treatment.

Area of Science:

  • Oncology
  • Reproductive Medicine
  • Endocrinology

Context:

  • Cancer therapies, including chemotherapy, radiation, and hormonal treatments, can significantly impact male gonadal function.
  • The germinal epithelium is particularly susceptible to cytotoxic damage, leading to subfertility or infertility more commonly than endocrine hypogonadism.

Purpose:

  • To review the impact of cancer treatments on male gonadal function.
  • To provide guidance on fertility preservation and management for male cancer patients.

Summary:

  • Gonadal damage severity correlates with chemotherapy type/dose (alkylating agents and procarbazine are highly gonadotoxic) and radiation dose.
  • Testicular damage can result from direct or scattered radiation.
  • Semen cryopreservation should be offered to men under 55 facing fertility-compromising cancer treatments.

Impact:

  • Highlights the importance of fertility preservation discussions for male cancer patients.
  • Emphasizes the need for long-term endocrine monitoring, especially after intensive treatments.
  • Informs clinical practice regarding fertility management and rehabilitation for cancer survivors.

More Related Videos

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

Related Concept Videos

Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male reproductive...
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...